A citation-based method for searching scientific literature

Imre Noth, Kevin J Anstrom, Sara Bristol Calvert, Joao de Andrade, Kevin R Flaherty, Craig Glazer, Robert J Kaner, Mitchell A Olman. Am J Respir Crit Care Med 2012
Times Cited: 299







List of co-cited articles
1083 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
51

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
46

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
45

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
985
37

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
882
36

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
30

A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.
David A Zisman, Marvin Schwarz, Kevin J Anstrom, Harold R Collard, Kevin R Flaherty, Gary W Hunninghake. N Engl J Med 2010
352
26

Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.
Ganesh Raghu, Juergen Behr, Kevin K Brown, Jim J Egan, Steven M Kawut, Kevin R Flaherty, Fernando J Martinez, Steven D Nathan, Athol U Wells, Harold R Collard,[...]. Ann Intern Med 2013
286
26

Anticoagulant therapy for idiopathic pulmonary fibrosis.
Hiroshi Kubo, Katsutoshi Nakayama, Masaru Yanai, Tomoko Suzuki, Mutsuo Yamaya, Mika Watanabe, Hidetada Sasaki. Chest 2005
297
23

Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis.
Fernando J Martinez, Joao A de Andrade, Kevin J Anstrom, Talmadge E King, Ganesh Raghu. N Engl J Med 2014
294
23

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.
Luca Richeldi, Ulrich Costabel, Moises Selman, Dong Soon Kim, David M Hansell, Andrew G Nicholson, Kevin K Brown, Kevin R Flaherty, Paul W Noble, Ganesh Raghu,[...]. N Engl J Med 2011
641
23

Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.
Harold R Collard, Christopher J Ryerson, Tamera J Corte, Gisli Jenkins, Yasuhiro Kondoh, David J Lederer, Joyce S Lee, Toby M Maher, Athol U Wells, Katerina M Antoniou,[...]. Am J Respir Crit Care Med 2016
539
23

Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis.
Michael Kreuter, Wim Wuyts, Elisabetta Renzoni, Dirk Koschel, Toby M Maher, Martin Kolb, Derek Weycker, Paolo Spagnolo, Klaus-Uwe Kirchgaessler, Felix J F Herth,[...]. Lancet Respir Med 2016
124
21

Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case-control study.
Vidya Navaratnam, Andrew W Fogarty, Tricia McKeever, Norma Thompson, Gisli Jenkins, Simon R Johnson, Gerard Dolan, Maruti Kumaran, Kate Pointon, Richard B Hubbard. Thorax 2014
65
32

Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review.
Ganesh Raghu, Valeria C Amatto, Jürgen Behr, Susanne Stowasser. Eur Respir J 2015
190
19

Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.
Michael Kreuter, Marlies S Wijsenbeek, Martina Vasakova, Paolo Spagnolo, Martin Kolb, Ulrich Costabel, Derek Weycker, Klaus-Uwe Kirchgaessler, Toby M Maher. Eur Respir J 2016
43
44

Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome.
J W Song, S-B Hong, C-M Lim, Y Koh, D S Kim. Eur Respir J 2011
428
19

Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.
Joyce S Lee, Harold R Collard, Kevin J Anstrom, Fernando J Martinez, Imre Noth, Rhonda S Roberts, Eric Yow, Ganesh Raghu. Lancet Respir Med 2013
239
18

Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis.
Michael Kreuter, Svenja Ehlers-Tenenbaum, Karin Palmowski, Jacques Bruhwyler, Ute Oltmanns, Thomas Muley, Claus Peter Heussel, Arne Warth, Martin Kolb, Felix J F Herth. PLoS One 2016
148
17

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial.
Talmadge E King, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Phil Hormel, Lisa Lancaster, Paul W Noble, Steven A Sahn, Javier Szwarcberg, Michiel Thomeer,[...]. Lancet 2009
342
17

BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis.
Talmadge E King, Jürgen Behr, Kevin K Brown, Roland M du Bois, Lisa Lancaster, Joao A de Andrade, Gerd Stähler, Isabelle Leconte, Sébastien Roux, Ganesh Raghu. Am J Respir Crit Care Med 2008
371
17

Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
Brett Ley, Harold R Collard, Talmadge E King. Am J Respir Crit Care Med 2011
876
17

The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study.
Richard B Hubbard, Chris Smith, Ivan Le Jeune, Jonathan Gribbin, Andrew W Fogarty. Am J Respir Crit Care Med 2008
149
16

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
16

BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis.
Talmadge E King, Kevin K Brown, Ganesh Raghu, Roland M du Bois, David A Lynch, Fernando Martinez, Dominique Valeyre, Isabelle Leconte, Adele Morganti, Sébastien Roux,[...]. Am J Respir Crit Care Med 2011
293
16

Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis.
Joyce S Lee, Jay H Ryu, Brett M Elicker, Carmen P Lydell, Kirk D Jones, Paul J Wolters, Talmadge E King, Harold R Collard. Am J Respir Crit Care Med 2011
256
15

Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS(®) trials.
Luca Richeldi, Vincent Cottin, Roland M du Bois, Moisés Selman, Toshio Kimura, Zelie Bailes, Rozsa Schlenker-Herceg, Susanne Stowasser, Kevin K Brown. Respir Med 2016
210
15

Pirfenidone in idiopathic pulmonary fibrosis.
H Taniguchi, M Ebina, Y Kondoh, T Ogura, A Azuma, M Suga, Y Taguchi, H Takahashi, K Nakata, A Sato,[...]. Eur Respir J 2010
608
15

Acute exacerbations of idiopathic pulmonary fibrosis.
Harold R Collard, Bethany B Moore, Kevin R Flaherty, Kevin K Brown, Robert J Kaner, Talmadge E King, Joseph A Lasky, James E Loyd, Imre Noth, Mitchell A Olman,[...]. Am J Respir Crit Care Med 2007
731
15

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
15

A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation.
David Weill, Christian Benden, Paul A Corris, John H Dark, R Duane Davis, Shaf Keshavjee, David J Lederer, Michael J Mulligan, G Alexander Patterson, Lianne G Singer,[...]. J Heart Lung Transplant 2015
680
14

How does comorbidity influence survival in idiopathic pulmonary fibrosis?
Charlotte Hyldgaard, Ole Hilberg, Elisabeth Bendstrup. Respir Med 2014
91
15

Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis.
Steven D Nathan, Ashwin Basavaraj, Cristina Reichner, Oksana A Shlobin, Shahzad Ahmad, Joseph Kiernan, Nelson Burton, Scott D Barnett. Respir Med 2010
106
13

Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease.
D B Sprunger, A L Olson, T J Huie, E R Fernandez-Perez, A Fischer, J J Solomon, K K Brown, J J Swigris. Eur Respir J 2012
71
18

Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial.
Ganesh Raghu, Rachel Million-Rousseau, Adele Morganti, Loyc Perchenet, Juergen Behr. Eur Respir J 2013
152
13

Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS.
Ulrich Costabel, Yoshikazu Inoue, Luca Richeldi, Harold R Collard, Inga Tschoepe, Susanne Stowasser, Arata Azuma. Am J Respir Crit Care Med 2016
151
13

Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis.
Martin Kolb, Ganesh Raghu, Athol U Wells, Jürgen Behr, Luca Richeldi, Birgit Schinzel, Manuel Quaresma, Susanne Stowasser, Fernando J Martinez. N Engl J Med 2018
104
13

Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study.
Birgitte F Sode, Morten Dahl, Sune F Nielsen, Børge G Nordestgaard. Am J Respir Crit Care Med 2010
64
18

Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study.
Evans R Fernández Pérez, Craig E Daniels, Darrell R Schroeder, Jennifer St Sauver, Thomas E Hartman, Brian J Bartholmai, Eunhee S Yi, Jay H Ryu. Chest 2010
271
12

The effect of anticoagulant therapy for idiopathic pulmonary fibrosis in real life practice.
S Tomassetti, J H Ruy, C Gurioli, C Ravaglia, M Buccioli, P Tantalocco, P A Decker, A Cavazza, A Dubini, V Agnoletti,[...]. Sarcoidosis Vasc Diffuse Lung Dis 2013
29
41

Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease.
Galina S Bogatkevich, Anna Ludwicka-Bradley, Paul J Nietert, Tanjina Akter, Joanne van Ryn, Richard M Silver. Arthritis Rheum 2011
76
15

A multidimensional index and staging system for idiopathic pulmonary fibrosis.
Brett Ley, Christopher J Ryerson, Eric Vittinghoff, Jay H Ryu, Sara Tomassetti, Joyce S Lee, Venerino Poletti, Matteo Buccioli, Brett M Elicker, Kirk D Jones,[...]. Ann Intern Med 2012
598
12

Obstructive sleep apnea is common in idiopathic pulmonary fibrosis.
Lisa H Lancaster, Wendi R Mason, James A Parnell, Todd W Rice, James E Loyd, Aaron P Milstone, Harold R Collard, Beth A Malow. Chest 2009
181
11

TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.
Justin M Oldham, Shwu-Fan Ma, Fernando J Martinez, Kevin J Anstrom, Ganesh Raghu, David A Schwartz, Eleanor Valenzi, Leah Witt, Cathryn Lee, Rekha Vij,[...]. Am J Respir Crit Care Med 2015
157
11

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis.
Lutz Wollin, Eva Wex, Alexander Pautsch, Gisela Schnapp, Katrin E Hostettler, Susanne Stowasser, Martin Kolb. Eur Respir J 2015
348
11

Incidence and prevalence of idiopathic pulmonary fibrosis.
Ganesh Raghu, Derek Weycker, John Edelsberg, Williamson Z Bradford, Gerry Oster. Am J Respir Crit Care Med 2006
799
11

Telomerase mutations in families with idiopathic pulmonary fibrosis.
Mary Y Armanios, Julian J-L Chen, Joy D Cogan, Jonathan K Alder, Roxann G Ingersoll, Cheryl Markin, William E Lawson, Mingyi Xie, Irma Vulto, John A Phillips,[...]. N Engl J Med 2007
811
11

Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis.
Steven D Nathan, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Ian Glaspole, Marilyn K Glassberg, David R Kardatzke, Monica Daigl, Klaus-Uwe Kirchgaessler, Lisa H Lancaster,[...]. Lancet Respir Med 2017
144
11

Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial.
Carlo Vancheri, Michael Kreuter, Luca Richeldi, Christopher J Ryerson, Dominique Valeyre, Jan C Grutters, Sabrina Wiebe, Wibke Stansen, Manuel Quaresma, Susanne Stowasser,[...]. Am J Respir Crit Care Med 2018
103
11

Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis.
David C J Howell, Robin H Johns, Joseph A Lasky, Bin Shan, Chris J Scotton, Geoffrey J Laurent, Rachel C Chambers. Am J Pathol 2005
159
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.